Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis

ClinicalTrials.gov ID: NCT03895372

Public ClinicalTrials.gov record NCT03895372. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 10:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A PHASE 2, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED, STUDY TO EVALUATE THE SAFETY AND EFFICACY OF PF-06826647 IN PARTICIPANTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS

Study identification

NCT ID
NCT03895372
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
179 participants

Conditions and interventions

Conditions

Interventions

  • PF-06826647 Drug
  • PF-06826647 or Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 26, 2019
Primary completion
May 20, 2020
Completion
Nov 25, 2020
Last update posted
Aug 26, 2021

2019 – 2020

United States locations

U.S. sites
24
U.S. states
9
U.S. cities
16
Facility City State ZIP Site status
Alliance Dermatology and Mohs Center Phoenix Arizona 85032
Center for Dermatology and Plastic Surgery/CCT Scottsdale Arizona 85260
Center for Dermatology and Plastic Surgery Scottsdale Arizona 85260
Anaheim Clinical Trials, LLC Anaheim California 92801
Kern Research. Inc. Bakersfield California 93301
California Dermatology & Clinical Research Institute Encinitas California 92024
Imaging Healthcare Specialists San Diego California 92103
Medderm Associates Dermatology San Diego California 92103
University Clinical Trials San Diego California 92123
Renstar Medical Research Ocala Florida 34470
MidState Skin Institute Ocala Florida 34471
Renstar Medical Research Ocala Florida 34471
Advanced Diagnostic Group Orange Park Florida 32073
Park Avenue Dermatology Orange Park Florida 32073
Leavitt Medical Associates of Florida d/b/a Ameriderm Research Ormond Beach Florida 32174
ForCare Clinical Research Tampa Florida 33613
Hamilton Research, LLC Alpharetta Georgia 30022
Epiphany Dermatology of Kansas, LLC Overland Park Kansas 66215
Qualmedica Research, LLC Owensboro Kentucky 42301
Owensboro Dermatology Associates Owensboro Kentucky 42303
DelRicht Research Baton Rouge Louisiana 70809
DelRicht Research Baton Rouge Louisiana 70816
Vital Prospects Clinical Research Institute, PC Tulsa Oklahoma 74136
Arlington Research Center, Inc. Arlington Texas 76011

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03895372, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 26, 2021 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03895372 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →